A paraprotein: MGUS, smouldering myeloma, myeloma or Waldenström?
- Look-alikes compared
A spike on protein electrophoresis is found in many healthy older people. Only a few have myeloma, and a handful of checks tell them apart.
What it is
A paraprotein (monoclonal protein, M-protein) is an antibody, or part of one, made by a single clone of plasma cells or B cells. Monoclonal gammopathy of undetermined significance (MGUS) is a small clone causing no harm; smouldering myeloma is a larger clone still causing no harm; multiple myeloma is a clone that damages organs; Waldenström macroglobulinaemia is an IgM-producing lymphoplasmacytic lymphoma.
The difference in one line
- Myeloma-defining organ damage (CRAB): high calcium, renal injury, anaemia, bone lytic lesions or fractures.
- Also myeloma-defining even without CRAB: 60% or more clonal plasma cells in the marrow, a very abnormal free light chain ratio, or more than one focal lesion on MRI.
- MGUS: M-protein under 30 grams per litre, fewer than 10% plasma cells in the marrow, no organ damage; about 1% a year progress.
- Smouldering myeloma: more protein or 10–60% plasma cells, still no organ damage; higher risk of progression.
- Light chains (Bence Jones protein) can block kidney tubules (cast nephropathy) or deposit as AL amyloid in heart, kidney, nerves and tongue.
- Waldenström: IgM paraprotein, big nodes or spleen, hyperviscosity (headache, blurred vision, bleeding), MYD88 L265P mutation.
- POEMS syndrome: polyneuropathy plus a clonal plasma cell disorder plus one more major criterion (sclerotic bone lesions, high VEGF or Castleman disease) and at least one minor feature; the light chain is lambda in over 95%.
- Solitary plasmacytoma: one mass of clonal plasma cells in bone or soft tissue, no CRAB, under 10% marrow plasma cells; radiotherapy treats it, and hidden marrow disease predicts progression to myeloma.
- Heavy chain diseases: the clone makes a truncated heavy chain (alpha, gamma or mu) with no light chain attached; alpha heavy chain disease is a small-intestine MALT lymphoma of young Mediterranean and Middle Eastern men.
How big is the clone, where is it, and is it hurting?
| Disorder | Clone size | Organ damage | What is done | Typical clue |
|---|---|---|---|---|
| MGUS | Small M-protein, under 10% marrow plasma cells | None | Watch, usually yearly | Found by chance |
| Smouldering myeloma | Larger, 10–60% plasma cells | None | Watch closely; some high-risk patients treated | Found by chance |
| Multiple myeloma | Usually 10% or more plasma cells | CRAB or a myeloma-defining marker | Treat | Back pain, anaemia, high calcium, kidney injury |
| Waldenström | IgM, lymphoplasmacytic cells | Hyperviscosity, cytopenias, nodes, spleen | Treat when symptomatic | Headache, blurred vision, bleeding gums |
| POEMS syndrome | Usually small; lambda light chain in over 95% | Polyneuropathy, sclerotic bone lesions, high VEGF, Castleman disease; organ enlargement, endocrine and skin changes, oedema, papilloedema | Radiotherapy for a dominant plasmacytoma; systemic therapy if lesions are diffuse | Neuropathy, often first labelled CIDP, with a lambda protein, thrombocytosis or papilloedema |
| Solitary plasmacytoma of bone | One bone mass of clonal plasma cells; marrow under 10% | Only from the lesion itself | Radiotherapy to the lesion | About half progress to myeloma within 10 years |
| Extramedullary plasmacytoma | One soft-tissue mass, most often in the head and neck (sinuses, nose and throat) | Only from the mass | Radiotherapy to the mass | About 30% progress to myeloma within 10 years |
| Heavy chain diseases | Truncated alpha, gamma or mu heavy chain, no light chain | Alpha: small-intestine lymphoma; gamma: lymphoma and autoimmune disease links | Treated as the underlying lymphoproliferative disorder | Immunofixation band in a heavy-chain lane with no kappa or lambda band |
In clinical practice
- An older patient with back pain, tiredness, high calcium and a rising creatinine: test for myeloma.
- Rouleaux on the smear and a high total protein with normal albumin suggest a paraprotein.
- Infections are common in myeloma because normal antibodies are suppressed.
- Sudden back pain with leg weakness in myeloma can be spinal cord compression: an emergency.
How it is confirmed
- Serum protein electrophoresis with immunofixation, serum free light chains, and urine for light chains.
- Count, calcium, creatinine, albumin; low-dose whole-body CT, MRI or PET-CT to look for bone lesions.
- Bone marrow aspirate and biopsy for the plasma cell percentage and genetics when myeloma or smouldering myeloma is suspected.
- Hypercalcaemia, kidney injury or cord compression in myeloma: same-day hospital care.
- Neuropathy with a lambda paraprotein, or CIDP that fails standard therapy: VEGF level and skeletal imaging for POEMS.
- Suspected solitary plasmacytoma: biopsy of the mass, marrow aspirate with flow cytometry, and MRI or PET-CT to exclude other lesions.
Common traps
- Using a plain bone scan to look for myeloma: lytic lesions without bone-building activity often do not show; use CT, MRI or PET.
- Missing light-chain myeloma because the serum electrophoresis looks normal: always add free light chains.
- Calling every paraprotein myeloma: most are MGUS and need only monitoring.
- Expecting a high alkaline phosphatase in myeloma: it is usually normal despite the bone destruction.
- Treating a lambda paraprotein with neuropathy as plain CIDP: thrombocytosis, oedema, papilloedema or failure of CIDP therapy point to POEMS, so VEGF and bone imaging follow.
Test yourself
Think of the answer, then tap the question to see it.
A 70-year-old has a small IgG paraprotein, normal calcium, kidney function and haemoglobin, and no bone lesions. What is the likely label and plan?
MGUS; monitor periodically, because only about 1% a year progress and treatment brings no benefit at this stage.
Why can a bone scan miss myeloma lesions?
Myeloma destroys bone without stimulating new bone formation, and the scan detects bone-building activity; CT, MRI or PET show the lesions.
Why must free light chains be measured even when serum electrophoresis looks normal?
Some myelomas make only light chains, which pass quickly into the urine and may not form a visible serum spike.
A man has a progressive demyelinating neuropathy, a small lambda paraprotein, thrombocytosis and a sclerotic bone lesion. Which syndrome is this, and how does it differ from myeloma?
POEMS syndrome. Its main problems are neuropathy, endocrine change and fluid overload, not bone pain or heavy marrow infiltration, and its bone lesions are sclerotic, not lytic.
Elsewhere in DurgiPedia
- Plasma cell disorders: MGUS to myeloma
- Multiple myeloma
- The kidney in plasma cell disorders
- B cell and plasma cell
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Multiple myeloma (MedlinePlus, US National Library of Medicine, 2026); Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Patient Version (National Cancer Institute (NCI), 2026); Free Light Chains (MedlinePlus, US National Library of Medicine, 2026); Waldenström macroglobulinemia (MedlinePlus Genetics, US National Library of Medicine, 2026); POEMS Syndrome: 2026 Update on Diagnosis, Risk-Stratification, and Management (American Journal of Hematology (Europe PMC), 2026); Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel (Journal of Hematology & Oncology (Europe PMC), 2018); Novel Laboratory Approaches in Heavy Chain Disease With Discordant Immunoglobulin Quantitation: A Case Report and Literature Review (Journal of Clinical Laboratory Analysis (Europe PMC), 2026); Gastrointestinal Alpha Heavy Chain Disease With Persistent Campylobacter Jejuni Colonization and Refractory Giardiasis (ACG Case Reports Journal (Europe PMC), 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
